Statement: the candidacy for the primary clinical trial involves patients being diagnosed with hormone receptor positive advanced breast cancer but disqualifies those who have received any former treatment for this advanced cancer
Primary_evidence: Inclusion Criteria:   Confirmed hormone receptor positive advanced breast cancer, postmenopausal women Exclusion Criteria:   Previous treatment for advanced breast cancer (previous treatment for early breast cancer is allowed).